SCHEMBL10746643

SCHEMBL10746643

Cc1nnc(-n2[se]c3ccccc3c2=S)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 6/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ EGFR P00533 1/20 0.35
▸ MPI P34949 2/20 0.35
▸ PHOSPHO1 Q8TCT1 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ QSOX1 O00391 1/20 0.35
▸ RGS12 O14924 1/20 0.35
▸ PMM2 O15305 1/20 0.35
▸ PLIN1 O60240 1/20 0.35
▸ GMNN O75496 1/20 0.35
▸ BBOX1 O75936 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYBB P04839 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10746484 0.84 METAP2 (0.54) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10745614 0.82 METAP2 (0.35) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10746138 0.81 ALDH1A1 (0.35) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10502231 0.81 METAP2 (0.37) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10747704 0.78 HTT (0.41) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10501619 0.78 EP300 (0.45) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10749736 0.76 KDM4E (0.35) METAP2KDM4EALDH1A1HPGDKMT2A
SCHEMBL10746112 0.75 NPC1 (0.43) METAP2ALDH1A1KMT2AMAPTMPI
SCHEMBL10744989 0.75 KAT2A (0.47) KDM4EALDH1A1KMT2AMEN1POLB
SCHEMBL10501392 0.75 METAP2 (0.34) METAP2KDM4EALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback